The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
Hansen, M. B., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,507
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
Endicott, J. A., & Ling, V. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001033 · Cited by 2,071
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Wacher, V. J., Wu, C., & Benet, L. Z. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130302 · Cited by 857
Artursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
The multidrug transporter, a double-edged sword.
Gottesman, M. M., & Pastan, I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37730-5 · Cited by 757
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Yin Win, K., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.050 · Cited by 1,452
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Kulkarni, S. A., & Feng, S.-S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0958-3 · Cited by 768
Enhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690
Vitamin E TPGS as a molecular biomaterial for drug delivery
Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586
Polymeric micelles drug delivery system in oncology
Gong, J., Chen, M., Zheng, Y., Wang, S., & Wang, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.012 · Cited by 570
The applications of Vitamin E TPGS in drug delivery
Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.006 · Cited by 523
Zhang, Z., & Feng, S.-S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.006 · Cited by 414
Polymeric micelles for oral drug delivery
Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., & Leroux, J.-C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.007 · Cited by 389
In vitro assessment of oral lipid based formulations
Porter, C. J. H., & Charman, W. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00182-x · Cited by 389
Development and application of hyaluronic acid in tumor targeting drug delivery
Luo, Z., Dai, Y., & Gao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.004 · Cited by 379
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., & Feng, S.-S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.005 · Cited by 373
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Polymeric micelles: nanocarriers for cancer-targeted drug delivery
Zhang, Y., Huang, Y., & Li, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0113-z · Cited by 367
Research progress on berberine with a special focus on its oral bioavailability
Liu, C.-S., Zheng, Y.-R., Zhang, Y.-F., & Long, X.-Y. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.02.001 · Cited by 363
Chen, W., Miao, Y.-Q., Fan, D.-J., Yang, S.-S., Lin, X., Meng, L.-K., & Tang, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9632-z · Cited by 363
Varma, M. V. S., & Panchagnula, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.003 · Cited by 361
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Dahan, A., & Hoffman, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.03.021 · Cited by 341
Intestinal lymphatic drug transport: an update
Porter, C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00151-x · Cited by 337
Mu, L., & Feng, S. S. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00025-1 · Cited by 328
Singh, B., Bandopadhyay, S., Kapil, R., Singh, R., & katare, O. P. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i5.10 · Cited by 325
Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current Progress
Dong, X., & Mumper, R. J. (2010) · Nanomedicine · doi:10.2217/nnm.10.35 · Cited by 317
Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao, J. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.002 · Cited by 314
Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo
Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., & Houin, G. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.03.001 · Cited by 307
Drug resistance in cancer: mechanisms and tackling strategies
Haider, T., Pandey, V., Banjare, N., Gupta, P. N., & Soni, V. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00138-7 · Cited by 282
Sjögren, E., Abrahamsson, B., Augustijns, P., Becker, D., Bolger, M. B., Brewster, M., Brouwers, J., Flanagan, T., Harwood, M., Heinen, C., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.010 · Cited by 279
Intestinal lymphatic transport for drug delivery
Yáñez, J. A., Wang, S. W. J., Knemeyer, I. W., Wirth, M. A., & Alton, K. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.019 · Cited by 278
Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots
Muthu, M. S., Kulkarni, S. A., Raju, A., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.036 · Cited by 265
Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles
Pan, J., & Feng, S.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.02.020 · Cited by 187
Trackable Mitochondria-Targeting Nanomicellar Loaded with Doxorubicin for Overcoming Drug Resistance
Zhang, Y., Zhang, C., Chen, J., Liu, L., Hu, M., Li, J., & Bi, H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07219 · Cited by 109
van Hasselt, P. M., Janssens, G. E. P. J., Slot, T. K., van der Ham, M., Minderhoud, T. C., Talelli, M., Akkermans, L. M., Rijcken, C. J. F., & van Nostrum, C. F. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.089 · Cited by 60
Li, Y., Li, R., Liu, Q., Li, W., Zhang, T., Zou, M., Li, H., Wu, T., Cheng, S., Su, Z., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00712 · Cited by 16
Sex-specific effects of excipients on oral drug bioavailability
Mai, Y., Madla, C. M., Shao, H., Qin, Y., Merchant, H. A., Murdan, S., & Basit, A. W. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122365 · Cited by 13
“…of P-glycoprotein (P-gp) substrates including doxorubicin, vinblastine, paclitaxel and colchicine through the inhibition of P-gp efflux function (Dintaman and Silverman, 1999), thereby influencing the outcome of oral drug absorption in Caco-2 cell lines (Flanagan, 2019; Martinez et al., 2022;…”
Metadata
- Authors
- Dintaman, J. M., & Silverman, J. A.
- Venue
- Pharmaceutical Research
- Published
- 1999-10
- Volume
- 16
- Issue
- 10
- Pages
- 1550-1556
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W66407225
- Cited by
- 426
- References
- 37
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.